Brief: Genetic Signatures Logs Q3 Sales A$3 Mln
April 29 (Reuters) - Genetic Signatures Ltd GSS.AX: Q3 FY2026 SALES WERE A$3 MILLION Further company coverage: GSS.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Genetic Signatures
See all newsBrief: Genetic Signatures Says Microba Shareholders To Hold 60% Of GSS On Merger
Australia's Genetic Signatures urges largest stakeholder to clarify merger intentions; shares rise
Brief: Genetic Signatures Receives Request From BCAL Diagnostics To Call General Meeting Of Shareholders
Brief: Genetic Signatures Requested BCAL Diagnostics To Clarify Details Of Shareholdings, Associates In Co
Brief: Genetic Signatures Announces Board Changes